Abstract:Ethnopharmacological relevance: A traditional Chinese medicine (TCM) prescription follows the principle of compatibility (peiwu) to achieve the fundamental purpose: to increase efficacy and reduce toxicity. Rhei rhizoma, commonly known as Chinese rhubarb, is the most frequently used herb with Radix Scutellariaee. This classic fixed compatibility is considered for heat-clearing, qi regulation and detoxifying to gain better efficacy and reduce cytotoxicity with respect to unilateral medicine. With this in mind, we propose it is highly promising to find ingredients in rhubarb to increase the bioavailability of baicalin. Aim of study: In the present study, effect of rhien on pharmacokinetic profile of baicalin in rat plasma was investigated, and the underlying mechanisms were partly dissected through intestinal absorption, metabolism and biliary excretion with in vivo, in vitro and in situ assays. Materials and methods: Pharmacokinetic analysis in rats was first performed to provide a general overview of the in vivo exposure of baicalin and rhein after co-administration, while the biliary excretion study provided insight to the effect of rhein on the transport of baicalin from hepatocytes to bile. In vitro incubation and inhibition studies in human/rat liver microsome and human/rat intestinal S9 fraction were conducted to elucidate the role of uridine diphosphate-glucuronosyltransferases (UGTs) on the hepatic and intestinal metabolism of baicalein (the aglycone of baicalin), and to determine whether rhein can affect the UGT-mediated glucuronidation of baicalein. In situ intestinal perfusion study was designed to investigate the effect of rhein on intestinal absorption of baicalin, and breast cancer resistance protein (BCRP) inhibitor was co-perfused as positive control to demonstrate the role of the efflux transporter, while BCRP-MDCK II cell(Madin-Daby canine kidney cell) model was used as an in vitro approach to further confirm the conclusion. Results: The AUC and C-max of baicalin were increased to 189.93% and 305.73%, respectively, and the clearance of baicalin was significantly decreased from 4.17 +/- 2.40 to 1.65 +/- 0.79 L/h/kg following oral co-administration of rhein. The AUC of baicalin was markedly increased and the biliary clearance was significantly decreased when baicalin and rhein were co-administered intravenously. The effect of rhein on the glucuronidation of baicalein in various subcellular fractions was examined, and it was found that rhein did not affect the UGT-mediated glucuronidation of baicalein. Results of in situ intestinal perfusion revealed that co-perfusion with Ko143 (a potent BCRP inhibitor) or rhein significantly reduced the cumulative excretion amount of baicalin, from 9.27 +/- 2.79 to 2.80 +/- 0.97 or 4.84 +/- 0.60 nM, respectively. Additionally, the efflux ratio P-app(BL-AP)/P-app(AP-BL) of baicalin in BCRP-MDCK II was decreased significantly in the presence of rhein or Ko143, which meant rhein could inhibit the BCRP-mediated efflux transport of baicalin. Conclusions: These results indicated that rhein can increase the bioavailability of baicalin by inhibiting BCRP-mediated efflux transport of baicalin in enterocytes and hepatocytes rather than by affecting the activity of UGT enzyme.

Influence of Croton Tiglium Seeds on the Pharmacokinetics of Anthraquinones in Radix Et Rhizoma Rhei

Pharmacokinetic Behavior of Argirein, Derived from Rhein, is Characterized As Slow Release and Prolonged T1/2 of Rhein in Rats

Pharmacokinetics and Pharmacodynamics of the Combination of Rhein and Curcumin in the Treatment of Chronic Kidney Disease in Rats

Influence of coptis Chinensis on pharmacokinetics of flavonoids after oral administration of radix Scutellariae in rats.

Comparative Pharmacokinetics of Active Anthraquinones Ingredients after Oral Administration of Rhei Radix Et Rhizoma and Niuhuang Jiedu Tablets to Rats

Pharmacokinetic Study of Rhein and Its Carboxyl-esterification Derivatives in Rats

Involvement of herb–herb interactions in the influences of Radix Scutellaria and Coptis Chinensis on the bioavailability of the anthraquinones form Rhei Rhizoma in rats

Influence of Drug Compatibility on Extractive Rate of Rhein of Yinchenhao Tang

The influence of rhein on the absorption of rehmaionoside D: In vivo, in situ, in vitro, and in silico studies

Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein

A Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone Ingredient

Determination and Pharmacokinetic Comparison of Rhein in Rats after Oral Dosed with Da-Cheng-Qi Decoction and Xiao-Cheng-Qi Decoction

Inhibition of Cytochrome P450 Enzymes by Rhein in Rat Liver Microsomes

A research update on the therapeutic potential of rhein and its derivatives

Anthraquinone Pharmacokinetics in Xiexin Decoction and the Different Combinations of Its Constituent Herbs

Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases

Pharmacokinetics and Pharmacodynamics of Rhubarb Anthraquinones Extract in Normal and Disease Rats

[The Pharmacokinetics of Rhein in 12 Healthy Volunteers after Oral Administration of Rhubarb Extract].

Comparative Pharmacokinetics and Metabolic Profile of Rhein Following Oral Administration of Niuhuang Shang Qing Tablets, Rhubarb and Rhein in Rats

Rhein: A Review of Pharmacological Activities

The Influence of Compatibility of Rhubarb and Radix Scutellariae on the Pharmacokinetics of Anthraquinones and Flavonoids in Rat Plasma